The choice for superior applied sciences is accelerating the demand for nuclear imaging units; Worldwide gross sales of $ 5.9 billion are anticipated by 2031

/ EIN News / – PUNE, India, July 16, 2021 (GLOBE NEWSWIRE) – The Global Nuclear Imaging equipment Market Share, Trends, Analysis and Forecast 2020-2030 provides insights into key developments, business strategies, research and development activities, supply chain analysis, competitive landscape and market composition analysis.

The nuclear imaging device market was valued at $ 3.65 billion in 2020 and is projected to reach $ 5.9 billion at a CAGR of 4.5% by 2031. Nuclear imaging modalities allude to a non-intrusive, simple indicative judgment that enables specialists to analyze patient suffering. To get images of how tissues and organs work, nuclear imaging uses radioisotopes that are embedded in the circulatory system, swallowed, or inhaled. For imaging, nuclear imaging hardware uses radioactive materials / tracers. These photos are used for the recognizable evidence and prediction of the disease by specialists and clinicians. Due to atherosclerosis, PET imaging can identify dynamic vascular macrocalcification along with the radioactive component 18F sodium fluoride.

Growth driver of the global nuclear imaging device market

Aspects that drive income growth in the business unit are fixated on tailor-made drugs and innovative technologies in radiotracers.

It is also postulated that development will improve with the expansion of drug companies and the increasing dominance of persistent diseases such as malignant growth, namely tumors and cancer. According to a study by the World Health Organization (WHO), long-term disease accounted for about 3/4 of all deaths worldwide in 2020.

View the entire report with table of contents:

Individuals do normal registration to test for disease-related signs, resulting in rapid demand for nuclear imaging tools. In the years to come, oncological screening techniques supported by clinical imaging machines will be relied on to drive significant development. A critical development in the forecast period is postulated in the cardiology market segment. This is due to the growing number of people with cardiovascular disease, increasing awareness of heart problems and increasing unhealthy lifestyles. The increasing development of the infection will develop fundamentally in the next few years. In the field of nuclear imaging, advances have been shown to ensure productive patient care for tumor diagnosis along with the accuracy of imaging techniques for clinical preparation.

For example, at the World Molecular Imaging Congress in Seattle in September 2018, Bruker presented a preclinical PET / CT-Si78 scanner for whole-body atomic imaging. The advances in micro-computed tomography (CT) and positron emission tomography (PET), as well as the imaging programming interface ParaVision 360, are combined in a single scanner.

In any case, significant spending on nuclear imaging equipment, the increasing use and complexity of assembly and hardware methodology, and the lack of qualified experts for such innovations are the main considerations that will partially limit the market development over the forecast period 2021-2031.

Access sample pages from this report:

Limited radiopharmaceutical stamina, high support costs, and a shortage of the radionuclide Tc99m, which is technetium 99, add difficulty in identifying improvements. Tc99m is a radioisotope that is widely used in nuclear medicine exams to map the patient’s body.

The leading market segments of the global nuclear imaging equipment market

The single photon emission computed tomography (SPECT) imaging models represented the largest share of income in the world market in 2020 due to their lower cost compared to crossover PET imaging models (positron emission tomography).

The oncology segment is expected to show a critical CAGR in the forecast period 2021-2031 due to the increasing incidence of tumors and cancers worldwide.

The medical clinics segment represented the largest share of sales among the end customer segments in the world market in 2020 due to the large number of approvals and the use of the most modern nuclear imaging models.

North America is expected to dominate the global nuclear imaging device market in 2019, while the Asia-Pacific province is expected to have the highest CAGR during the forecast period. The high development in this district is due to the increasing rate of persistent illnesses, the increasing awareness of the advantages of early and timely notification of illness and the improvement of the medical care models in the region.

Associated report:

Global Deep Brain Stimulation Devices Market:

Global Scoliosis Management Market:

Global Sickle Cell Anemia Treatment Market:

It also illustrates a huge CAGR rate over the standard time period in the Asia Pacific Province. The development is due to the increased incidence of illness in connection with vital approaches and demand in the medical care sector. The nuclear medication process in Japan is best in class, with a critical increase in the number of half SPECT / CT tests in recent years.

In addition, the evolving clinical trips for medical purposes are important aspects affecting the development of the province.

In 2018, Regal Philips, which is part of the Netherlands and the Local Health District (Australia), and the Nepean Blue Mountains Local Health District (Australia) signed two 20-year agreements for Managed Equipment Services in which Philips agreed to refurbish, broker, upgrade, replace and provide maintenance management services for all major clinical imaging assemblies in Australia and the Asia Pacific Province.

The key players in the Global Nuclear Imaging Devices Market are:

Siemens Healthineers, Koninklijke Philips NV, GE Healthcare, Toshiba Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., Mediso Medical Imaging Systems Co., Ltd., CMR Naviscan Corporation, Digirad Corporation, SurgiEye GmbH and Positron Corporation and others.

Buy this report:

Key Global Segments of Nuclear Imaging Devices Market:

Based on type

  • SPECT imaging systems
  • PET imaging systems
  • Planar scintigraphy imaging systems
  • Other.

Based on the application type

  • neurology
  • oncology
  • cardiology
  • Other

Based on the type of end user

  • Hospitals
  • Imaging centers
  • Academic and Research Centers
  • Other

By region

  • North America
    • US
    • Canada
    • Rest of north america
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of APAC
  • Middle East & Africa
    • United Arab Emirates
    • South Africa
    • Saudi Arabia
    • Rest of MEA
  • South America
    • Brazil
    • Rest of south america

Insight SLICE is a market research and strategy consulting company. The company offers tailor-made market research studies off the shelf. The company’s focus is on strategy consulting for the provision of end-to-end solutions. For more information, please contact our research and advisory team at

Contact us:


Insight SLICE

Telephone (USA): +1 707 736 6633



You just read:

News provided by

July 16, 2021, 6:30 PM GMT

EIN Presswire’s priority is source transparency. We don’t allow opaque clients, and our editors try to carefully weed out false and misleading content. If, as a user, you see something that we have overlooked, please make us aware of it. Your help is welcome. ONE Presswire, Everyone’s Internet News Presswire ™, seeks to define some of the boundaries that are appropriate in the world today. Please see our editorial guidelines for more information.

Submit your press release

Comments are closed.